Anti-Aging Techniques That Have Real Science Behind Them

The Evidence Problem in Longevity Research

Most longevity research faces a fundamental challenge: the gold standard — a randomized controlled trial measuring actual lifespan extension in humans — would take 80 years and cost billions. As a result, researchers use proxy measures: biological age clocks, inflammatory markers, disease incidence, and animal models. This means nearly all "anti-aging" evidence is either preliminary, animal-based, or correlational. Where the evidence grade matters, we flag it below.

Caloric Restriction

Caloric restriction (CR) — reducing calorie intake by 20–40% while maintaining adequate nutrition — is the most robustly studied longevity intervention in biology. It extends healthy lifespan in yeast, worms, flies, fish, rodents, and non-human primates. The mechanism involves activation of sirtuins, AMPK, and suppression of mTOR and IGF-1 signaling — pathways that collectively shift cellular metabolism from growth toward maintenance and repair.

The CALERIE-2 trial (2013–2015) randomized 218 healthy, non-obese adults to 25% caloric restriction for two years. Participants achieved about 11.9% restriction on average. Results included significant reductions in metabolic syndrome markers, cardiovascular risk factors, inflammatory markers (TNF-alpha, C-reactive protein), and thyroid hormone levels consistent with slower metabolism. A follow-up analysis using epigenetic clocks found measurable deceleration in biological aging.

The practical reality: sustained 25% CR is extremely difficult to maintain, and there are risks including muscle loss, bone density reduction, and hormonal disruption if implemented carelessly. The findings are promising enough to motivate research into CR mimetics — drugs that activate the same pathways without requiring starvation.

Intermittent Fasting and Time-Restricted Eating

Intermittent fasting (IF) covers several patterns: alternate-day fasting, 5:2 (five normal days, two very-low-calorie days), and time-restricted eating (TRE, e.g., eating only within an 8-hour window). The appeal is that these protocols trigger similar metabolic pathways to CR — AMPK activation, autophagy induction — without permanent calorie reduction.

A 2019 review in the New England Journal of Medicine by de Cabo and Mattson found consistent evidence in animals that IF extends lifespan and delays disease. Human data is more modest: TRE reliably improves insulin sensitivity, blood pressure, and inflammatory markers in overweight adults. Whether it extends lifespan in already-healthy humans is unknown. The current evidence supports IF as metabolically beneficial, especially for those with prediabetes or metabolic syndrome — but it is not a verified longevity intervention in humans yet.

NAD+ Precursors: NMN and NR

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential to energy metabolism and DNA repair. NAD+ levels decline approximately 50% between age 40 and 60, and this decline has been mechanistically linked to many features of aging in animal models. Two supplements — nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) — are precursors that the body converts into NAD+.

In mice, NMN supplementation has been shown to reverse age-associated physiological decline including loss of muscle strength, energy metabolism, eye function, and insulin sensitivity. Human trials are encouraging but limited. A 2022 clinical trial published in Science found that NMN supplementation (300 mg/day for 60 days) in postmenopausal women with prediabetes improved muscle insulin sensitivity and signaling. A separate trial found NR safely raised blood NAD+ levels. What neither study has shown yet — because no human trial is long enough — is life extension.

The evidence grade: preliminary positive signals from animal studies, early-stage human safety and biomarker data, no human longevity outcome data yet. NMN and NR appear safe at typical doses. Whether they will translate into meaningful lifespan extension in humans is genuinely unknown.

Senolytics: Clearing Zombie Cells

As cells age or are damaged, some enter a state called senescence — they stop dividing but do not die. These senescent cells, sometimes called "zombie cells," accumulate with age and secrete a cocktail of inflammatory proteins called the senescence-associated secretory phenotype (SASP), which damages neighboring cells and drives systemic inflammation.

Senolytics are compounds that selectively eliminate senescent cells. The most studied are dasatinib (a cancer drug) and quercetin (a plant flavonoid), often used together. In a 2018 Nature Medicine paper, Mayo Clinic researchers transplanted senescent cells into young mice — the mice rapidly developed physical dysfunction and died earlier than controls. Senolytic treatment reversed these effects. In older mice, senolytics improved physical function and extended median lifespan.

Human trials are in early stages. A 2019 pilot study in patients with idiopathic pulmonary fibrosis (a disease driven by cellular senescence) found improved physical function after three weeks of dasatinib and quercetin. Larger trials are ongoing. For healthy individuals, the risk-benefit calculation for taking prescription senolytics is currently unclear — but the basic science is some of the most compelling in longevity research.

Sleep Quality

Sleep is perhaps the most underrated and most accessible anti-aging intervention. During deep sleep, the brain's glymphatic system — a waste-clearance network — flushes out metabolic byproducts including amyloid-beta and tau proteins implicated in Alzheimer's disease. Growth hormone is predominantly released during slow-wave sleep, and tissue repair accelerates. Chronic sleep deprivation (less than 6 hours per night) is associated with accelerated telomere shortening, increased inflammatory markers, impaired insulin sensitivity, and higher all-cause mortality.

A 2021 study found that poor sleep quality at age 50 was associated with a 30% higher risk of developing dementia 25 years later, independent of other risk factors. Optimizing sleep is free, has no side effects, and the evidence base is enormous. Practical measures: consistent sleep and wake times, cooler room temperature (65–68°F), no bright screens in the hour before bed, and eliminating alcohol near bedtime (which fragments sleep architecture even if it helps you fall asleep faster).

Mediterranean and Plant-Rich Diets

The Mediterranean diet — characterized by high intake of vegetables, legumes, whole grains, fish, and olive oil; moderate red wine; and low intake of red meat and processed foods — has more longevity outcome data than any other dietary pattern. The PREDIMED trial, a large Spanish randomized controlled trial, found that Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by approximately 30% compared to a low-fat control diet.

The Blue Zones — Sardinia (Italy), Okinawa (Japan), Nicoya (Costa Rica), Ikaria (Greece), and Loma Linda (California) — all have diets dominated by whole plants, legumes, and minimal processed food. While these are observational, the consistency across five geographically and culturally distinct populations is striking. The Mediterranean diet also consistently shows favorable effects on epigenetic aging clocks in intervention studies.

What Does Not Have Good Evidence

For completeness: resveratrol (the red wine compound) showed dramatic results in yeast and mice but failed to replicate in human trials at achievable doses. Most commercial "longevity supplements" have no meaningful human outcome data. Hormone replacement (testosterone, HGH) has some evidence for specific deficiencies but significant risks when used in already-healthy adults. The supplement market is vast and largely unregulated — the best filter remains peer-reviewed human clinical trials.

Calculate your exact age →